Difference between revisions of "Henson SM, et al. Curr. Opin. Immunol. (2012) cited as Ref 719 in DOI: 10.1038/s41392-020-0110-5 (Q9982)"
Jump to navigation
Jump to search
(Created a new Item: #quickstatements; #temporary_batch_1589975872009) |
(Created claim: Page(s) (P105): 476-481, #quickstatements; #temporary_batch_1590074839150) |
||||||||||||||
(10 intermediate revisions by the same user not shown) | |||||||||||||||
Property / First Author string | |||||||||||||||
+ | Henson SM | ||||||||||||||
Property / First Author string: Henson SM / rank | |||||||||||||||
+ | Normal rank | ||||||||||||||
Property / Second Author string | |||||||||||||||
+ | Riddell NE | ||||||||||||||
Property / Second Author string: Riddell NE / rank | |||||||||||||||
+ | Normal rank | ||||||||||||||
Property / Third Author string | |||||||||||||||
+ | Akbar AN | ||||||||||||||
Property / Third Author string: Akbar AN / rank | |||||||||||||||
+ | Normal rank | ||||||||||||||
Property / DOI Identifier | |||||||||||||||
+ | |||||||||||||||
Property / DOI Identifier: 10.1016/j.coi.2012.04.001 / rank | |||||||||||||||
+ | Normal rank | ||||||||||||||
Property / PubMed ID | |||||||||||||||
+ | |||||||||||||||
Property / PubMed ID: 22554789 / rank | |||||||||||||||
+ | Normal rank | ||||||||||||||
Property / Publication Date | |||||||||||||||
+ | 2012
| ||||||||||||||
Property / Publication Date: 2012 / rank | |||||||||||||||
+ | Normal rank | ||||||||||||||
Property / Published In Name String | |||||||||||||||
+ | Curr. Opin. Immunol. | ||||||||||||||
Property / Published In Name String: Curr. Opin. Immunol. / rank | |||||||||||||||
+ | Normal rank | ||||||||||||||
Property / Volume | |||||||||||||||
+ | 24 | ||||||||||||||
Property / Volume: 24 / rank | |||||||||||||||
+ | Normal rank | ||||||||||||||
Property / title | |||||||||||||||
+ | Properties of end-stage human T cells defined by CD45RA re-expression (English) | ||||||||||||||
Property / title: Properties of end-stage human T cells defined by CD45RA re-expression (English) / rank | |||||||||||||||
+ | Normal rank | ||||||||||||||
Property / Page(s) | |||||||||||||||
+ | 476-481 | ||||||||||||||
Property / Page(s): 476-481 / rank | |||||||||||||||
+ | Normal rank | ||||||||||||||
links / sliswiki / name | links / sliswiki / name | ||||||||||||||
+ |
Latest revision as of 15:50, 21 May 2020
Cited in: "Targeting cancer stem cell pathways for cancer therapy" in Signal Transduct Target Ther; 2020 ; 5 8
Language | Label | Description | Also known as |
---|---|---|---|
English |
Henson SM, et al. Curr. Opin. Immunol. (2012) cited as Ref 719 in DOI: 10.1038/s41392-020-0110-5
|
Cited in: "Targeting cancer stem cell pathways for cancer therapy" in Signal Transduct Target Ther; 2020 ; 5 8
|
Statements
Henson SM
0 references
Riddell NE
0 references
Akbar AN
0 references
2012
0 references
Curr. Opin. Immunol.
0 references
24
0 references
Properties of end-stage human T cells defined by CD45RA re-expression (English)
0 references
476-481
0 references